(Reuters) -CVS Well being Corp slashed its annual revenue forecast and missed Wall Road estimates for first-quarter earnings on Wednesday, as elevated demand for non-urgent procedures elevated medical prices at its medical insurance enterprise.
The U.S. healthcare large reduce its per-share adjusted earnings forecast for 2024 to at the least $7.00 from at the least $8.30, including it anticipates the surge in medical procedures at its unit that homes well being insurer Aetna to persist.
Shares of the corporate fell 9.7% to $61.15 in premarket buying and selling. They’ve fallen about 14% to date this 12 months, by way of Tuesday’s shut.
U.S. well being insurers have needed to deal with rising medical prices over the previous few quarters following increased demand for procedures, particularly amongst older adults, that had been delayed throughout the pandemic.
CVS mentioned in February it was seeing an increase in hip and knee surgical procedures, medical companies associated to the eyes, dental work, in addition to vaccinations together with the RSV shot over the past three months of 2023.
The corporate’s well being care advantages section, which homes the Aetna unit, recorded medical value ratio – the share of premiums spent on healthcare – of 90.4% for the primary quarter. That in contrast with 84.6% a 12 months earlier, and above analysts’ common estimate of 88.43%, based on LSEG information.
Aetna can be anticipated to face stress after the federal government introduced 2025 reimbursement charges to suppliers of Medicare Benefit well being plans under expectations, elevating worries a couple of squeeze on margins.
Humana final week pulled its already trimmed 2025 revenue forecast, citing the disappointing charges.
CVS, which withdrew its 2025 adjusted earnings forecast of $10 per share in August, mentioned in February it was concentrating on low double-digit share progress.
On an adjusted foundation, the corporate reported a revenue of $1.31 per share for the three months ended March 31, under analysts’ common estimate of $1.69.
(Reporting by Christy Santhosh and Leroy Leo in Bengaluru; Enhancing by Sriraj Kalluvila)